Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDIV × Everolimus × Clear all

Phase

Status

Sponsor Class

OTHER 180 INDUSTRY 34 NIH 8 OTHER_GOV 5 NETWORK 5 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Proflavine 2 Microbial Collagenase 2 pegfilgrastim 1 macimorelin 1 Uracil 1 Tegafur 1 Sirolimus 1 Mifepristone 1 Gemcitabine 1 Everolimus 1 Darbepoetin alfa 1 Corlux 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Treiber, Gerhard

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡